Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Gains from Investment Securities: 2019-2025

Historic Gains from Investment Securities for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $59,000.

  • Harmony Biosciences Holdings' Gains from Investment Securities fell 99.64% to $59,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $56.5 million, marking a year-over-year decrease of 34.61%. This contributed to the annual value of $7.2 million for FY2024, which is 13.31% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Gains from Investment Securities stood at $59,000, which was down 99.82% from $33.2 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Gains from Investment Securities ranged from a high of $41.6 million in Q2 2024 and a low of $59,000 during Q3 2025.
  • Its 3-year average for Gains from Investment Securities is $16.0 million, with a median of $16.5 million in 2024.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first spiked by 4,970.39% in 2023, then crashed by 99.64% in 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Gains from Investment Securities (Quarterly) stood at $2.0 million in 2021, then surged by 50.23% to $2.9 million in 2022, then surged by 297.21% to $11.7 million in 2023, then spiked by 80.38% to $21.1 million in 2024, then plummeted by 99.64% to $59,000 in 2025.
  • Its Gains from Investment Securities stands at $59,000 for Q3 2025, versus $33.2 million for Q2 2025 and $2.2 million for Q1 2025.